Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward
about
Autism Spectrum Disorders and Drug Addiction: Common Pathways, Common Molecules, Distinct Disorders?Dynorphin Controls the Gain of an Amygdalar Anxiety CircuitA Trigger for Opioid Misuse: Chronic Pain and Stress Dysregulate the Mesolimbic Pathway and Kappa Opioid SystemArchitectural Representation of Valence in the Limbic System.Stretchable multichannel antennas in soft wireless optoelectronic implants for optogeneticsNeuroinflammation-a co-occurring phenomenon linking chronic pain and opioid dependence.Reduced Vglut2/Slc17a6 Gene Expression Levels throughout the Mouse Subthalamic Nucleus Cause Cell Loss and Structural Disorganization Followed by Increased Motor Activity and Decreased Sugar ConsumptionNociceptin/Orphanin FQ Receptor Structure, Signaling, Ligands, Functions, and Interactions with Opioid Systems.Chemogenetic and Optogenetic Activation of Gαs Signaling in the Basolateral Amygdala Induces Acute and Social Anxiety-Like StatesDopamine and opioid systems interact within the nucleus accumbens to maintain monogamous pair bondsStress-Induced Reinstatement of Nicotine Preference Requires Dynorphin/Kappa Opioid Activity in the Basolateral Amygdala.A GABAergic Projection from the Centromedial Nuclei of the Amygdala to Ventromedial Prefrontal Cortex Modulates Reward Behavior.Nicotinic and opioid receptor regulation of striatal dopamine D2-receptor mediated transmission.Homeostasis Meets Motivation in the Battle to Control Food Intake.Allostatic Mechanisms of Opioid Tolerance Beyond Desensitization and DownregulationMolecular and Circuit-Dynamical Identification of Top-Down Neural Mechanisms for Restraint of Reward Seeking.Kappa Opioid Receptors Mediate Heterosynaptic Suppression of Hippocampal Inputs in the Rat Ventral Striatum.New Technologies for Elucidating Opioid Receptor Function.The long-term effects of stress and kappa opioid receptor activation on conditioned place aversion in male and female California mice.The dynamic interaction between pain and opioid misuse.Microfluidic neural probes: in vivo tools for advancing neuroscience.How contexts promote and prevent relapse to drug seeking.Emerging Role for Nucleus Accumbens Medium Spiny Neuron Subtypes in Depression.Role of the Dynorphin/Kappa Opioid Receptor System in the Motivational Effects of Ethanol.Cell-Type-Specific Epigenetic Editing at the Fosb Gene Controls Susceptibility to Social Defeat Stress."Quite a Profoundly Strange Experience": An Analysis of the Experiences of Salvia divinorum Users.Cocaine Experience Enhances Thalamo-Accumbens N-Methyl-D-Aspartate Receptor Function.Memories of Opiate Withdrawal Emotional States Correlate with Specific Gamma Oscillations in the Nucleus Accumbens.Locus coeruleus to basolateral amygdala noradrenergic projections promote anxiety-like behavior.Spotlight on pain: optogenetic approaches for interrogating somatosensory circuits.Pathway- and Cell-Specific Kappa-Opioid Receptor Modulation of Excitation-Inhibition Balance Differentially Gates D1 and D2 Accumbens Neuron Activity.Drive and Reinforcement Circuitry in the Brain: Origins, Neurotransmitters, and Projection Fields.Chronic ethanol exposure increases inhibition of optically targeted phasic dopamine release in the nucleus accumbens core and medial shell ex vivo.Optogenetic activation of amygdala projections to nucleus accumbens can arrest conditioned and unconditioned alcohol consummatory behavior.Dynorphin and κ-Opioid Receptor Dysregulation in the Dopaminergic Reward System of Human Alcoholics.Flexible Near-Field Wireless Optoelectronics as Subdermal Implants for Broad Applications in Optogenetics.Preparation and implementation of optofluidic neural probes for in vivo wireless pharmacology and optogenetics.Involvement of activated brain stress responsive systems in excessive and "relapse" alcohol drinking in rodent models: implications for therapeutics.Contemporary strategies for dissecting the neuronal basis of neurodevelopmental disorders.Ginsenoside Re protects methamphetamine-induced dopaminergic neurotoxicity in mice via upregulation of dynorphin-mediated κ-opioid receptor and downregulation of substance P-mediated neurokinin 1 receptor.
P2860
Q26768231-B819CDE2-EFC7-4FCB-A249-A4A0952F6A95Q27319741-53F214E2-025A-48F6-B63F-6F326D93D8F3Q28074686-E0260A8C-7B38-42C6-8A48-AF39C5AC7D7BQ30355371-26AD758B-7ADA-4AF5-A8A3-153D7543D6BAQ30832387-33009879-F2D9-433C-8469-3A73A1D2C33EQ33602197-B6196794-0889-4208-9AF6-B8724697CCDCQ36152395-34A8D385-9A8F-475D-A387-0B81102540FDQ36744366-41D8EC40-5BD2-49AB-B0A9-DE379A604D6FQ37006297-FB107F9D-6C18-40E8-8E62-AE914CD46491Q37149935-F0677F62-BF0F-477E-992C-446814DC4EC7Q37270938-263BA15A-7307-4B78-B597-19E141E61F7AQ37372041-D12E082E-BF20-40A8-8ADC-FD344DE7DC65Q37439216-E2C3B39D-0099-432E-9D2E-0A1FF8B0CC8DQ37444966-DA61BEE0-6A02-4E35-B80E-5B3363D213C6Q37590161-3683D57E-D77D-403A-891A-46B74B5EA2ADQ38371922-8FDCBB92-6986-432F-A5DC-41C341C252D4Q38713108-CE05CFF3-981C-4034-A360-466EB1383701Q38718788-2389E996-80EE-476E-8E03-1197C0E70EBAQ38720488-3CDF6FB3-D315-42D5-9E9D-255EC0AC9AAFQ38731968-90E278C9-787C-422A-B522-CD19B565F073Q38738786-E20E445E-F929-405D-B745-44A10A37AE20Q38950401-2E13BEEA-4838-41BE-8F08-C4D19C1E3887Q39015823-A8EF4ADB-DB13-4FD1-9F14-E0D7C5CBFCD5Q39251520-0DB2C64B-A0B7-4B4A-867D-5E61766BD5A6Q39306654-72BCBAEC-9916-472E-9598-FFBB5222FD96Q39769038-24E4FAF7-BAE6-4C65-9816-581A9105A492Q40742869-B7FE9179-77FA-4695-9CAD-54C1ABEF8A4BQ40990836-106EB5BA-D3B7-4530-B2B9-88250BD7C2EDQ41329923-CE4BDA12-A91E-4F03-97F7-97984048E83CQ42669411-C01A150D-29D2-443F-9D6D-9B983279C96CQ44342408-F8F91F45-BF99-4EE7-BD66-56DF3A5A873DQ47315933-6C28A3DD-46A3-4E23-BED6-5E8E48B35B0AQ47319192-7AA5FF33-1921-40B6-BE31-97A1690AFFFFQ47328907-E27C0A06-4AE6-453C-8AD4-5A08E2D07AAAQ47550488-20DC20E2-9856-45A5-97E4-336EB8F31CE3Q47992567-ADE454F6-3392-450A-AF73-4C848C4E04F4Q48050521-B94A23B2-4ABF-4670-9778-1E7B13F1A490Q52317998-44B88CEC-408C-4768-9BAB-833742ED7329Q52351832-26C92361-2F86-482A-9859-A1FD0326984EQ53082241-95834A2A-07A4-4A90-8B3E-A3D5CF6BB1BD
P2860
Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward
@ast
Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward
@en
Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward
@nl
type
label
Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward
@ast
Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward
@en
Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward
@nl
prefLabel
Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward
@ast
Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward
@en
Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward
@nl
P2093
P2860
P50
P3181
P1433
P1476
Distinct Subpopulations of Nucleus Accumbens Dynorphin Neurons Drive Aversion and Reward
@en
P2093
Bradford B Lowell
Chang-O Pyo
Gavin P Schmitz
Gunchul Shin
John A Rogers
Jordan G McCall
Julio M Bernardi
Michael J Krashes
Michael R Bruchas
Nicole A Crowley
P2860
P304
P3181
P356
10.1016/J.NEURON.2015.08.019
P407
P577
2015-09-02T00:00:00Z